Company Legal Name
Latest Valuation
Founded Year
Headquarter
Amplemarket operates an AI-powered sales platform that enables B2B companies to streamline their go-to-market strategies and enhance sales productivity. Founded in 2018 and headquartered in San Francisco, the company leverages artificial intelligence to automate and optimize various aspects of the sales process, from lead generation to customer engagement. Since its inception, Amplemarket has established itself as a notable player in the sales technology sector, achieving a valuation of $80 million. The platform addresses the growing demand for intelligent sales automation tools among B2B organizations seeking to improve conversion rates and accelerate revenue growth in increasingly competitive markets.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
